Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCFinancial_Report.xls
10-Q - FORM 10-Q - HI TECH PHARMACAL CO INCd399017d10q.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR7.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR6.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR8.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR2.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR5.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR3.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR4.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR1.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR9.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR49.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR23.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR40.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR38.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR27.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR34.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR50.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR28.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR21.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR17.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR16.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR48.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR55.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR37.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR56.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR29.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR15.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR32.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR13.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR54.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR10.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR43.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR18.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR53.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR12.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR35.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR36.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR19.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR42.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR24.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR45.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR25.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR46.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR20.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR41.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR22.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR11.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR39.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR47.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR26.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR44.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR30.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR14.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR52.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR33.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR51.htm
EX-32 - EX-32 - HI TECH PHARMACAL CO INCd399017dex32.htm
EX-31.2 - EX-31.2 - HI TECH PHARMACAL CO INCd399017dex312.htm
EX-31.1 - EX-31.1 - HI TECH PHARMACAL CO INCd399017dex311.htm
v2.4.0.6
Fair Value Measurements (Tables)
6 Months Ended
Oct. 31, 2012
Fair Value Measurements [Abstract]  
Schedule of financial liabilities subject to fair value measurements

The Company’s financial liabilities subject to fair value measurements as of October 31, 2012 was as follows:

 

                 

Fair Value Measurements Using Fair Value Hierarchy

 
    Fair Value     Level 3  

Contingent payment liability

  $ 8,927,000     $ 8,927,000  
   

 

 

   

 

 

 

The Company’s financial liabilities subject to fair value measurements as of April 30, 2012 were as follows:

 

                 

Fair Value Measurements Using Fair Value Hierarchy

 
    Fair Value     Level 3  

Contingent payment liability

  $ 10,103,000     $ 10,103,000  
   

 

 

   

 

 

 
Roll forward of contingent payment liability

The following table presents the roll forward of the Company’s contingent payment liability as of October 31, 2012.

 

         

Contingent payment liability – May 1, 2012

  $     10,103,000  

Payments on contingent liability

    (1,438,000

Interest expense

    262,000  
   

 

 

 

Contingent payment liability – October 31, 2012

  $ 8,927,000